Glenn Pierce's most recent trade in Voyager Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Glenn F. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 14 Jul 2022 | 9,512 | 16,788 (0%) | 0% | 6.7 | 63,730 | Common Stock |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director, Interim CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director, Interim CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 26,300 | 26,300 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Glenn Pierce | Director, Interim CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn Pierce | Director, Interim CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |